Home > Financial Ratios > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Financial Ratios

GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Financial Ratios History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Operational & Financial Ratios
   Earnings Per Share (Rs) 61.1554.7634.8336.05100.04
   CEPS(Rs) 65.0858.7038.9439.7526.50
   DPS(Rs) 57.0054.0032.0032.0090.00
   Book NAV/Share(Rs) 134.77116.06105.47102.89157.19
   Tax Rate(%) 26.3226.3827.7227.3551.12
Margin Ratios
   Core EBITDA Margin(%) 31.0128.5624.0122.5421.20
   EBIT Margin(%) 33.3630.5921.6123.4921.73
   Pre Tax Margin(%) 33.3030.5621.5723.4421.67
   PAT Margin (%) 24.5422.5015.5917.0310.59
   Cash Profit Margin (%) 26.1124.1217.4318.8712.49
Performance Ratios
   ROA(%) 25.4025.1517.8715.7610.11
   ROE(%) 48.7649.4333.4327.5818.39
   ROCE(%) 66.7967.6446.4938.0637.72
   Asset Turnover(x) 1.041.121.150.930.95
   Sales/Fixed Asset(x) 6.116.205.845.826.03
   Working Capital/Sales(x) 2.312.742.973.061.79
Efficiency Ratios
   Fixed Capital/Sales(x) 0.160.160.170.170.17
   Receivable days 24.4522.7819.9820.3421.37
   Inventory Days 40.6044.5747.5050.8754.91
   Payable days 172.70174.99144.03143.05140.69
Valuation Parameters
   PER(x) 37.3452.5555.8036.7316.62
   PCE(x) 35.0949.0249.9033.3162.75
   Price/Book(x) 16.9424.7918.4212.8710.58
   Yield(%) 2.501.881.652.425.41
   EV/Net Sales(x) 9.7612.639.226.547.84
   EV/Core EBITDA(x) 25.6435.7730.8923.5130.67
   EV/EBIT(x) 26.4737.5438.9425.3832.89
   EV/CE(x) 16.4524.2617.9212.225.68
   M Cap / Sales 10.1213.009.536.908.59
Growth Ratio
   Net Sales Growth(%) 1.938.566.21-0.8012.05
   Core EBITDA Growth(%) 9.9228.3213.968.0318.19
   EBIT Growth(%) 11.7054.18-2.417.3270.71
   PAT Growth(%) 11.6957.23-2.9159.5832.55
   EPS Growth(%) 11.6957.23-3.39-63.97373.19
Financial Stability Ratios
   Total Debt/Equity(x) -----
   Current Ratio(x) 2.031.791.841.882.18
   Quick Ratio(x) 1.771.541.491.531.87
   Interest Cover(x) 515.59960.03454.77462.54391.29
   Total Debt/Mcap(x) -----

Compare Financial Ratios of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹45,921.8 Cr 7% 6.7% -4.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹457,073.0 Cr 7.3% 8.4% 13.1% Stock Analytics
DIVIS LABORATORIES ₹307,147.0 Cr 15.3% 24.1% 63% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,626.0 Cr 1% 2.5% 33.4% Stock Analytics
DR REDDYS LABORATORIES ₹115,685.0 Cr 1% 15.9% 14% Stock Analytics
CIPLA ₹113,589.0 Cr 0.4% 7.9% -6.2% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

7%

6.7%

-4.6%

SENSEX

5.5%

13.3%

-3.4%


You may also like the below Video Courses